LLY
BULL
2026-05-15
Overnight Institutional Flow Signal
Score
8/10
Move
1.1%
Flow
$337.0M
AI Trade Thesis
LLY BULL. Aggressive $313M bullish flow targeting $1,100+ as the market absorbs the ex-dividend dip and pivots back to the 'Foundayo' oral delivery growth story. Entry near $1,000 support provides a high-convexity setup with a target of $1,132 (52-week high). Risk: Increased regulatory scrutiny on GLP-1 pricing structure.
Flow Breakdown
Call Volume
$313.7M
Put Volume
$23.3M
Flow Intent
DIRECTIONAL
Catalyst
Technical Breakout
Recommended Setup
ContractO:LLY260626C01070000
Contract Score9.494/10
Risk/Reward0.2:1
Delta0.32
Key Levels
Resistance$1022.82
Support$920.27
Price$1006.70
SMA 50 / 200$940 / $920
52W Range$624 — $1134
News & Catalyst Analysis
Key Headline
Eli Lilly's New Oral GLP-1 'Foundayo' Beats Semaglutide in Head-to-Head Trials; Analysts Raise Targets to $1,164
News Summary
The -1.1% move coincides with LLY's ex-dividend date (May 15), masking intense institutional accumulation following a 'blowout' Q1 earnings report and positive Phase 3 data for the oral GLP-1 'Foundayo'. Institutional flow of $313M is aggressively bullish, suggesting the minor price dip is being used as a high-conviction entry point for the next leg of the weight-loss drug cycle.
Flow Intent Analysis
The massive $313M bullish premium entering during a minor ex-dividend price adjustment indicates strategic positioning for a post-dividend recovery rather than hedging against a downside trend.
One email a week. Catch up in five minutes.
The GammaRips weekly briefing — engine state, the latest deep-dive, and the picks on the public ledger. No firehose, no FOMO.